Learn More
Medchemexpress LLC Propanamide, 3-[[3-[4-[[3-(β-D-glucopyranosyloxy)-5-(1-methylethyl)-1H-pyrazol-4-yl]methyl]-3-methylphenox... | 666842-36-0 | 98.8% | 536.62 g·mol⁻¹ | C26H40N4O8 | 5MG

Supplier: Medchemexpress LLC HY1237975MG
KGA-2727 is a selective, high-affinity, orally active inhibitor of the sodium-glucose cotransporter 1 (SGLT1) used in research on glucose transport and metabolic effects. It exhibits Ki values in the low nanomolar range for human and rat SGLT1 and has demonstrated antidiabetic efficacy in preclinical studies.
- Selective SGLT1 inhibition with low nanomolar Ki values.
- High affinity and oral activity observed in preclinical models.
- Demonstrated antidiabetic efficacy in rodent studies.
- Supplied at high purity (≈98.8%), suitable for research use.
- Offered as solid packs and ready-to-use DMSO solution formats.
- Storage guidance provided for solid and solution stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.